el-Kebbi I M, Roser S, Pollet R J, Cushman S W, Wilson C M
Department of Medicine, Atlanta VA Medical Center, GA.
Biochem J. 1994 Jul 1;301 ( Pt 1)(Pt 1):35-40. doi: 10.1042/bj3010035.
We have used the impermeant photoaffinity label 2-N-4-(1-azi-2,2,2-trifluoroethyl)benzoyl-[2-3H] 1,3-bis-(D-mannos-4-yloxy)-2-propylamine (ATB-[2-3H]BMPA) to identify and quantify the glucose transporters on the surface of BC3H-1 cells, a continuously cultured skeletal-muscle cell line lacking the MyoD transcription factor required for cell fusion. ATB-[2-3H]BMPA was used in combination with immunoprecipitation of the GLUT1 glucose transporter, the only isoform expressed in these cells. The total cellular GLUT1 content was also determined by photolabelling and immunoprecipitation after cell permeabilization with digitonin (0.025%). In glucose-starved cells, 85% of the glucose transporters were present at the cell surface in the basal state, with little change in response to insulin (200 nM), correlating with lack of additional 2-deoxyglucose uptake in response to insulin. Feeding the cells with glucose (25 mM) for 24 h resulted in an 80% decrease in the total GLUT1 content relative to starved cells, of which only 25% were present on the cell surface. This was associated with an 85% decrease in 2-deoxyglucose uptake. In addition, acute stimulation of the fed cells with insulin or phorbol 12-myristate 13-acetate (PMA) led to an increase in GLUT1 at the cell surface, and, in correspondence, an increase in 2-deoxyglucose uptake by approx. 2- and 4-fold respectively. We conclude that exofacial photoaffinity labelling of glucose transporters with ATB-[2-3H]BMPA in the presence and absence of digitonin, followed by specific immunoprecipitation, provides an accurate measure of total and cell-surface glucose transporters in differentiated BC3H-1 muscle cells. This technique demonstrates that glucose pre-feeding (1) decreases the total number of GLUT1 and (2) redistributes the majority of the remaining transporters to an intracellular site, where they can now be translocated to the cell surface in response to insulin and PMA.
我们使用了非渗透性光亲和标记物2-N-4-(1-叠氮基-2,2,2-三氟乙基)苯甲酰基-[2-³H]1,3-双-(D-甘露糖-4-氧基)-2-丙胺(ATB-[2-³H]BMPA)来鉴定和定量BC3H-1细胞表面的葡萄糖转运体,BC3H-1是一种连续培养的骨骼肌细胞系,缺乏细胞融合所需的MyoD转录因子。ATB-[2-³H]BMPA与GLUT1葡萄糖转运体的免疫沉淀相结合使用,GLUT1是这些细胞中唯一表达的同种型。在用洋地黄皂苷(0.025%)使细胞通透后,还通过光标记和免疫沉淀来测定细胞内GLUT1的总量。在葡萄糖饥饿的细胞中,85%的葡萄糖转运体在基础状态下存在于细胞表面,对胰岛素(200 nM)的反应变化很小,这与胰岛素刺激后2-脱氧葡萄糖摄取没有增加相关。用葡萄糖(25 mM)喂养细胞24小时导致相对于饥饿细胞,GLUT1的总量减少了80%,其中只有25%存在于细胞表面。这与2-脱氧葡萄糖摄取减少85%相关。此外,用胰岛素或佛波醇12-肉豆蔻酸酯13-乙酸酯(PMA)对喂食后的细胞进行急性刺激导致细胞表面的GLUT1增加,相应地,2-脱氧葡萄糖摄取分别增加了约2倍和4倍。我们得出结论,在有和没有洋地黄皂苷的情况下,用ATB-[2-³H]BMPA对葡萄糖转运体进行外表面光亲和标记,随后进行特异性免疫沉淀,可准确测量分化的BC3H-1肌肉细胞中总的和细胞表面的葡萄糖转运体。这项技术表明,预先用葡萄糖喂养(1)会减少GLUT1的总数,(2)会将大多数剩余的转运体重分布到细胞内位点,在那里它们现在可以响应胰岛素和PMA而转运到细胞表面。